Evidence map›Paper›PMID 40419369›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025

[Study on the value of abnormal prothrombin in the diagnosis of HBV-related hepatocellular carcinoma].

J M Zhang, S X Zhao, L D Liu, F Han, W G Ren, X Q Wu, M J Sun, J J Song, Y M Nan

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Key epidemiological data and recommended prevention and control measures for primary liver cancer].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J M ZhangDepartment of Integrated Traditional Chinese and Western Medicine, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China.
S X ZhaoKey Laboratory for Liver Fibrosis of Chronic Liver Disease in Hebei Province, International Research Center for Molecular Diagnosis of Liver Cancer, Hebei Province International Cooperation Base, Shijiazhuang 050051, China.
L D LiuDepartment of Integrated Traditional Chinese and Western Medicine, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China Key Laboratory for Liver Fibrosis of Chronic Liver Disease in Hebei Province, International Research Center for Molecular Diagnosis of Liver Cancer, Hebei Province International Cooperation Base, Shijiazhuang 050051, China.
F HanDepartment of Integrated Traditional Chinese and Western Medicine, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China Key Laboratory for Liver Fibrosis of Chronic Liver Disease in Hebei Province, International Research Center for Molecular Diagnosis of Liver Cancer, Hebei Province International Cooperation Base, Shijiazhuang 050051, China.
W G RenDepartment of Integrated Traditional Chinese and Western Medicine, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China Key Laboratory for Liver Fibrosis of Chronic Liver Disease in Hebei Province, International Research Center for Molecular Diagnosis of Liver Cancer, Hebei Province International Cooperation Base, Shijiazhuang 050051, China.
X Q WuDepartment of Integrated Traditional Chinese and Western Medicine, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China.
M J SunDepartment of Integrated Traditional Chinese and Western Medicine, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China.
J J SongDepartment of Integrated Traditional Chinese and Western Medicine, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China.
Y M NanDepartment of Integrated Traditional Chinese and Western Medicine, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China Key Laboratory for Liver Fibrosis of Chronic Liver Disease in Hebei Province, International Research Center for Molecular Diagnosis of Liver Cancer, Hebei Province International Cooperation Base, Shijiazhuang 050051, China.

Funding

Hebei Province Medical Application Technology Tracking Project GZ2024048Key Research and Development Plan Projects of Hebei Province 23377705DThe Hebei Province Nontural Science Foundation Precision Medicine Voint Fund Cultivation Project H2022206451The Introduction of Foreign Intelligence Program in Hebei Province 2024
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularHepatitis B, ChronicLiver NeoplasmsProtein PrecursorsProthrombinalpha-FetoproteinsBiomarkersFemalegamma-GlutamyltransferaseHepatitis B virusHumansMaleMiddle AgedRetrospective StudiesROC Curveacarboxyprothrombinalpha-FetoproteinsBiomarkersgamma-GlutamyltransferaseProtein PrecursorsProthrombin

Identifiers

PMID40419369
PMCPMC12899194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.